PMEL and melanoma: Importantly, primary skin tumors developed in ret transgenic mice were found to express several differentiation MAA such as TRP-1, TRP-2, gp100 and tyrosinase, which have been previously identified as targets for tumor-reactive T cells in melanoma patients [29,30].